Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

32.7K
Overview
32.7K
Viral Recombination00:57

Viral Recombination

24.8K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Qualitative analyses of contributing factors to central line-associated bloodstream infections and catheter-associated urinary tract infections during the COVID-19 pandemic.

American journal of infection control·2026
Same author

Preservation of an extravascular implantable cardioverter-defibrillator during sternotomy and surgical myectomy.

HeartRhythm case reports·2026
Same author

Host-virus determinants of Ebola virus persistence in a human cerebral organoid model.

Nature microbiology·2026
Same author

When Lassa Fever Travels: Lessons from a Nosocomial Outbreak in Guinea.

The Journal of infectious diseases·2026
Same author

[<sup>18</sup>F]FDG PET/CT is a quantitative tool to probe vascular inflammation and immune system metabolic activation in atherosclerotic nonhuman primates.

EJNMMI research·2026
Same author

NEJM Outbreaks Update - Andes Hantavirus.

The New England journal of medicine·2026

Related Experiment Video

Updated: Dec 28, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.9K

Ebola virus disease.

Shevin T Jacob1,2, Ian Crozier3, William A Fischer4

  • 1Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Nature Reviews. Disease Primers
|February 22, 2020
PubMed
Summary
This summary is machine-generated.

Ebola virus disease (EVD) is a severe illness with a high fatality rate. Recent research has led to approved vaccines and therapeutics, improving EVD prevention and patient care.

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.5K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.0K

Related Experiment Videos

Last Updated: Dec 28, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

36.9K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.5K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

7.0K

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Ebola virus disease (EVD) is a severe, often fatal zoonotic illness.
  • Characterized by high case-fatality rates, fever, gastrointestinal distress, and organ dysfunction.
  • Transmission occurs through direct contact with infected bodily fluids or contaminated materials.

Purpose of the Study:

  • To summarize current understanding and management of Ebola virus disease.
  • To highlight recent advancements in medical countermeasures and treatment strategies.
  • To inform prevention and clinical care based on recent outbreak data.

Main Methods:

  • Literature review of EVD outbreaks and research.
  • Analysis of diagnostic methods including PCR and immunoassays.
  • Evaluation of clinical trial data for vaccines and therapeutics.

Main Results:

  • EVD outbreaks have significant public health impact.
  • Approved EBOV-targeted vaccines and monoclonal antibody therapeutics show survival benefits.
  • Recent outbreaks have enhanced understanding of viral persistence and patient care needs.

Conclusions:

  • EVD remains a critical global health concern requiring ongoing vigilance.
  • Advancements in vaccines and therapeutics offer improved control and treatment options.
  • New insights from recent outbreaks are refining EVD prevention and clinical management strategies.